drugset / Trial / NCT01956201

Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin

NCT01956201

Phase 3 Unknown 476 enrolled Chong Kun Dang Pharmaceutical
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Atorvastatin and Fenofibrate compared with atorvastatin monotherapy in mixed hypercholesterolemic patients.

Timeline

Start
2013-12
Primary completion
2016-08
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Fenofibrate Small molecule 160 mg Oral
Background Atorvastatin Small molecule 20 mg Oral